Login to Your Account

Number 1: Ebola

To say that 2014 was a good year for the biopharma industry would be a radical understatement. The flourishing capital markets, the record-breaking number of companies successfully going public via initial public offerings and the validation of scientific breakthroughs that only a few years ago had been mere theories all made for a banner year for the sector. more »

Our Habitat for All Things Science
Osteoporosis drugs could prevent, treat HER-driven cancers

Bisphosphonates have been used since the early 1990s in two indications. They are most famous as osteoporosis drugs, where even off-patent, Fosamax (alendronate sodium, Merck & Co. Inc.) – only one of several bisphosphonates – raked in more than $700 million in sales in 2013, according to Thomson Reuters Cortellis.

They are also used in cancer "primarily to prevent bone metastases and their consequences, but never for the cancer itself," Mone Zaidi told BioWorld Today.